NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/08/2025
Voltar para busca
Dado oficial do USPTO
EPITOPEA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
EPITOPEA
ST13
US500000098426932Classe
1, 5, 35, 42
Pedido
98426932
Registro
7877770
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
05/08/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 35, 42
Data de depósito
29/02/2024
Data de registro
05/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/08/2025
Última transação
05/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
16
Localização do titular
Cambridge, GB
Examinador
DEFORD, JEFFREY S
Unidade examinadora
M60
Localização atual
INTENT TO USE SECTION
Titulares e representantes
Titulares
Epitopea Limited
Representantes
Scott D. Locke Dorf Nelson & Zauderer LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Cells for scientific or research purposes; chemical substances for use in the manufacture of medicinal and pharmaceutical products; Chemicalsreagents and substances for medical research purposes; Immunoassay reagentsother than for medical or veterinary use; Chemicals for use in immuno-assay testing other than for medical or veterinary use; Immunoassays based on polypeptides for determining immunological profileother than for medical or veterinary use; Diagnostic preparations and reagents for scientific or research use; Test kits consisting primarily of peptidesnucleic acidsbuffersreagents for scientific or research use; Nucleic recombinant acids other than for medical or veterinary purposes; Nucleic acid sequencing programsother than for medical or veterinary use; Chemical reagents for use in oncology research; Reagents for medical research; Diagnostic reagentsother than for medical or veterinary use; Cell culture reagents for scientific and research use; Biological preparations for use in cell cultures other than for medical or veterinary use; Substances for use in genetic probe assay kitsother than for medical or veterinary use; Antibodies for scientific purposes
Classe 5
Pharmaceuticalmedical or veterinary preparations and substances for the treatment of cancer and diseases of the immune system; Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; Compounds for treating cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations for the prevention of cancer and diseases of the immune system for use in the fields of medicinehealthoncologyimmunology; biological compounds or preparations for the treatment of cancer and diseases of the immune system; biological compounds or preparations for the prevention of cancer and diseases of the immune system; Therapeutic preparations for cancer and diseases of the immune system; Genetic markers for therapeutic or diagnostic use; Cells for medical use; pharmaceutical preparations for the prevention or treatment of tumors; Pharmaceutical preparations for activating cellular function; Cell growth media for growing cells for medical use; Cellular function activating agents for medical purposes; Reconstituted cells for medical treatments; Preparations for detecting genetic predispositions for medical purposes; Pharmaceutical preparations for the prevention or treatment of immune system related diseases and disorders; Immunomodulators; Immunostimulants; Pharmaceutical preparations for immunity adjustment; Immunoassay reagents for medical use; Immunotherapeutic agents for use in treating bacterial infections; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Vaccines; Tumor antigens for medical use; antigens for medical use; viral antigens for medical use; endogenous antigens for medical use; exogenous antigens for medical use; Biological compounds for use in the targeted pharmaceutical therapies; Proteins with diagnostic and therapeutic uses for medical use; Proteins for medical use; Diagnostic reagents for medical use; Reagents and substances for use in testing for medical purposes; Diagnostic and testing preparations for clinicalmedical and medical laboratory use; Diagnostic and testing apparatus in the field of modulating therapeutics; Biomarkers for medical use; Nucleic acid sequences for medical purposes; Nucleic recombinant acids for medical use; Biological preparations and biological compounds for the treatment of cancer and diseases of the immune system; Biological reagents for medical use; Biological tissue cultures for medical purposes; Indicators for medical diagnosis; In vivo diagnostic scanning agents for medical use; Diagnostic agents for pharmaceutical or medical use; Diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of peptidesnucleic acidsbuffersreagentsfor medical purposes; Medical diagnostic test strips for use in the field of cancer and diseases of the immune system; Pharmaceutical preparations for the treatment of cancers
Classe 35
Compilation of statistical data relating to medical research for business purposes; Database management; Data processing; Data processingsystematization and management; Data processing services in the field of healthcare; Promoting public awareness of diseasesavailable medical treatments and disease prevention practices; Promoting public awareness of medical conditionsdiagnosis of medical conditions and prevention of medical conditions; Consultancy and advisory services relating to all of the aforesaid services
Classe 42
Scientific research for medical purposes in the area of cancerous diseases; Research and development in the fields of oncologyimmunology; Research and development services in the fields of oncology and immunology research and development; Drug discovery; drug development; Medical and scientific researchconducting clinical trials for others; Research relating to genetics; Research and development in the field of therapeutics; Research and development in the fields of biotechnologypharmaceuticalsdiagnostic preparationsvaccinesmedicinesmolecular sciencesclinical trials and therapeutics; Scientific laboratory services; Laboratory testing and analysis of materials; Biological research laboratory services; Services of a chemical laboratory; Development of biochemical reagents; Research and development of biological drug delivery platforms; Development of computer softwarecomputing methods and algorithms; Computer programming; Database design; Online database maintenance for others; Design and development of computer software for use with medical technology; Design and development of software for medical diagnostic or veterinary diagnostic purposes; Design and development of computer systems for data inputoutputprocessingdisplay and storage; technical surveying; Analysis of technical dataoncology and immunology data; Research relating to data processing; Provision of research information and data relating to medical and veterinary research and development; Scientific research in the field of oncology and immunology conducted using databases; Consultancyinformation and advisory services relating to all of the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
05/08/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
16/07/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
16/07/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/02/2025
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
05/02/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/12/2024
PUBO
PUBLISHED FOR OPPOSITION
10/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/11/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/09/2024
GNRT
NON-FINAL ACTION E-MAILED
17/09/2024
CNRT
NON-FINAL ACTION WRITTEN
17/09/2024
DOCK
ASSIGNED TO EXAMINER
17/09/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2024
NWAP
NEW APPLICATION ENTERED
29/02/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EPITOPEA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.